High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala

High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala

Abstract INTRODUCTION: Geographical, epidemiological, and environmental differences associated with therapeutic response to Chagas etiological treatment have been previously discussed. This study describes high seroconversion rates 72 months after benznidazole treatment in patients under 16 years f...

Full description

Bibliographic Details
Main Authors: Lucia Brum-Soares, Juan-Carlos Cubides, Iris Burgos, Carlota Monroy, Leticia Castillo, Selene González, Pedro Albajar Viñas, Pedro Pablo Palma Urrutia
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Benznidazole
Chagas
Chronic infection
Guatemala
Seroconversion
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600721&lng=en&tlng=en

Similar Items

Similar Items